Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

NUTRITION MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S AND COLITIS (GEDIIB).

Created on 13 Aug 2026

Authors

Daniéla Oliveira Magro, Carina Rossoni, Raquel Rocha, Ligia Yukie Sassaki, Marcello Imbrizi, Isadora Sayuri Macedo Tuma, Carina Andriatta Blume, Cristina Henschel Matos, Ryan Nunes Yoshio Yoshihara, Maria Izabel Lamounier de Vasconcelos, Patricia Hanako Ribeiro Sato, Maria Paula Carlin Cambi, Claiza Barretta LA Bella, Matheus Freitas Cardoso de Azevedo, Julio Maria Fonseca Chebli, Cristiane Kibune Nagasako, Júlio Pinheiro Baima, Claudio Saddy Rodrigues Coy, Paulo Gustavo Kotze, Cristina Flores, Rogério Saad-Hossne, Eduardo Garcia Vilela

Published in

Arquivos de gastroenterologia. Volume 63. Pages e26042. Epub Aug 10, 2026.

Abstract

Inflammatory bowel diseases (IBD), specifically Crohn's disease and ulcerative colitis, are multifactorial conditions. Genetic and behavioral factors are associated with disease development and influence its progression. It is known that diet plays a role in this pathogenic process.
to position nutritional and dietary factors in the management of IBD.
This consensus was developed by nutritionists, gastroenterologists, and colorectal surgeons, members of GEDIIB (Brazilian Organization for Crohn's disease and colitis). A systematic review of the most recent evidence was conducted to support the recommendations/statements. All recommendations and statements were endorsed by stakeholders and IBD experts in a modified Delphi panel, achieving a consensus rate of at least 80%.
the recommendations were directed according to disease activity and severity. Nutritional screening and diagnosis, nutritional therapy in the active and remission phases of the disease, dietary management and exclusion diets, and supplementation were addressed. The consensus is targeted at nutritionists, general practitioners, gastroenterologists, and surgeons interested in managing adults with IBD. It supports decision-making by health insurance companies, regulatory agencies, and health institutional managers.

PMID:
42585492
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement